Salmonella enterica is one of the most ubiquitous enteropathogenic bacterial species on
earth, and comprises more than 2500 serovars. Widely known for causing non-typhoidal …

One of the major breakthroughs in the history of medicine is undoubtedly the discovery of
antibiotics. Their use in animal husbandry and veterinary medicine has resulted in healthier …

Class D β-lactamase-mediated resistance to β-lactams has been increasingly reported
during the last decade. Those enzymes also known as oxacillinases or OXAs are widely …

Abstract β-lactams have a long history in the treatment of infectious diseases, though their
use has been and continues to be confounded by the development of resistance in target …

Extended-spectrum β-lactamase (ESBL) producing gram-negative bacilli are a growing
concern in human medicine today. When producing these enzymes, organisms (mostly K …

Four isolates of Klebsiella pneumoniae obtained from patients at a Maryland medical centre
exhibited reduced susceptibility to carbapenems and were found to produce the novel, class …

Epidemiologic data of a study of a multistate outbreak of food‐borne salmonellosis due to
resistant Salmonella enterica serovar Newport carrying a common ampicillin and …

Salmonella is one of the leading causes of foodborne illness in countries around the world.
Treatment of Salmonella infections, in both animals and humans has become more difficult …

Salmonella resistant to extended-spectrum cephalosporins (ESCs) have emerged
worldwide since 1988. By 2004, 43 countries had reported this public health problem …

Despite the discovery of novel β-lactamases such as extended-spectrum β-lactamases
(ESBLs), imported AmpC, and carbapenem-hydrolyzing β-lactamases at least a decade …